Rees, D. G., He, Y., Hammond, S. A., Cobbold, M., Giraldo, N., Cemerski, S., . . . Abhishek, S. An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release. BMJ Publishing Group.
Chicago Style (17th ed.) CitationRees, D Gareth, et al. An Affinity-modulated T Cell Engager Targeting Claudin 18.2 Shows Potent Anti-tumor Activity with Limited Cytokine Release. BMJ Publishing Group.
MLA (9th ed.) CitationRees, D Gareth, et al. An Affinity-modulated T Cell Engager Targeting Claudin 18.2 Shows Potent Anti-tumor Activity with Limited Cytokine Release. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.